|
PROSC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.03700381615113E-11 |
| Normal-vs-Stage3 |
6.54859999560387E-09 |
| Normal-vs-Stage4 |
2.807100E-04 |
| Stage1-vs-Stage2 |
7.534800E-01 |
| Stage1-vs-Stage3 |
5.654100E-02 |
| Stage1-vs-Stage4 |
8.555800E-01 |
| Stage2-vs-Stage3 |
1.550600E-01 |
| Stage2-vs-Stage4 |
9.606200E-01 |
| Stage3-vs-Stage4 |
2.644400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
2.684100E-02 |
| Caucasian-vs-AfricanAmerican |
7.369800E-01 |
| Caucasian-vs-Asian |
7.921800E-01 |
| AfricanAmerican-vs-Asian |
8.668600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
1.690210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62581059726108E-12 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.64390723256247E-12 |
| Normal-vs-Extreme_Obese |
3.441000E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.796400E-01 |
| Normal_Weight-vs-Obese |
2.636400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.402400E-01 |
| Extreme_Weight-vs-Obese |
1.829000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.449200E-01 |
| Obese-vs-Extreme_Obese |
3.516800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.90249999999903E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(81-100Yrs) |
1.0507000047788E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.294200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.933200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.534000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.756000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.609400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.831200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.06421554796543E-14 |
| Normal-VS-KIRP CIMP |
2.01730000481959E-08 |
| Normal-VS-Unclassified PRCC |
2.34146035893446E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.191610E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.298000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.100200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.534000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.413800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.702400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62458935193399E-12 |
| Normal-vs-N1 |
3.47649999898891E-08 |
| Normal-vs-N2 |
3.36349999963126E-07 |
| N0-vs-N1 |
8.842100E-02 |
| N0-vs-N2 |
8.539200E-01 |
| N1-vs-N2 |
3.329600E-01 |
|
|
